, Volume 166, Issue 1, pp 47–50 | Cite as

Two Cases of Vaginitis Caused by Itraconazole-Resistant Saccharomyces cerevisiae and a Review of Recently Published Studies

  • Vincenzo Savini
  • Chiara Catavitello
  • Assunta Manna
  • Marzia Talia
  • Fabio Febbo
  • Andrea Balbinot
  • Francesco D’Antonio
  • Giovanni Di Bonaventura
  • Claudio Celentano
  • Marco Liberati
  • Raffaele Piccolomini
  • Domenico D’Antonio


Genitourinary infections caused by non-Candida yeasts are uncommon, and especially due to Saccharomyces cerevisiae. We describe the cases of two adult females with vulvovaginal infections caused by itraconazole-resistant S. cerevisiae who made a full recovery after oral fluconazole therapy. We also provide a concise review of recently published studies on this topic.


Saccharomyces cerevisiae Vaginitis Azoles 



The Authors thank Mrs. Annarita Perfetti for her help.


  1. 1.
    Passos XS, Costa CR, Araujo CR, Nascimento ES, e Souza LK, Fernandes Ode F, Sales WS, Silva Mdo R. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital. Mycopathologia. 2007;163(3):145–51.PubMedCrossRefGoogle Scholar
  2. 2.
    Zerva L, Hollis RJ, Pfaller MA. In vivo susceptibility and DNA typing of Saccharomyces cerevisiae clinical isolates. J Clin Microb. 1996;34(2):3031–4.Google Scholar
  3. 3.
    McCullough MJ, Clemons KV, Farina C, McCusker JH, Stevens DA. Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method. J Clin Microb. 1998;36(2):557–62.Google Scholar
  4. 4.
    Garcia-Martos P, Mira J, Galan F, Hernandez JM. Sexual forms of yeasts in clinical samples. Mycopathologia. 1996–1997;136(2):67–70.CrossRefGoogle Scholar
  5. 5.
    Sobel JD, Vaquez J, Lynch M, Meriwether C, Zervos MJ. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis. 1993;16:93–9.PubMedGoogle Scholar
  6. 6.
    Figuereido VT, de Assis Santos D, Resende MA, Hamdan JS. Identification and in vivo antifungal susceptibility testing of 2000 clinical isolates of Candida spp. responsible for fingernail infections. Mycopathologia. 2007;164(1):27–33.CrossRefGoogle Scholar
  7. 7.
    National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts. Approved standard M27-A2. 2nd ed. Wayne: National Committee for Clinical Laboratory Standards; 2002.Google Scholar
  8. 8.
    Clemons KV, McCusker JH, Davis RW, Stevens DA. Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae. J Infect Dis. 1994;169:859–67.PubMedGoogle Scholar
  9. 9.
    McCusker JH, Clemons KV, Stevens DA, Davis RW. Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice, is associated with the ability to grow at 42°C and form pseudohyphae. Infect Immun. 1994;62:5447–55.PubMedGoogle Scholar
  10. 10.
    Munoz P, Bouza E, Cuenca-Estrella M, Eiros JM, Pérez MJ, Sánchez-Somolinos M, Rincón C, Hortal J, Peláez T. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40(11):1625–34.PubMedCrossRefGoogle Scholar
  11. 11.
    Kusumaningtyas E, Widiastuti R, Maryam R. Reduction of aflatoxin B1 in chicken feed by using Saccharomyces cerevisiae, Rhizopus oligosporus and their combination. Mycopathologia. 2006;162(4):307–11.PubMedCrossRefGoogle Scholar
  12. 12.
    de Resende MA, Alterthum F. Effect of nystatin, amphotericin B and amphotericin B methyl ester on Saccharomyces cerevisiae with different lipid composition. Mycopathologia. 1990;112(3):165–72.PubMedCrossRefGoogle Scholar
  13. 13.
    Evans EGV, Richardson MD. Medical mycology: a practical approach. Oxford (UK): IRL Press; 1989.Google Scholar
  14. 14.
    Larone DH. Medically important fungi–a guide to identification. 3rd ed. Washington: ASM Press; 1995.Google Scholar
  15. 15.
    Fiol JB. Systematic studies of Saccharomyces: oxidases and vitamin requirements. Mycopathologia. 1976;58(1):49–58.PubMedCrossRefGoogle Scholar
  16. 16.
    Kurtzman CP, Smiley MJ, Baker FL. Scanning electron microscopy of ascospores of Debaryomyces and Saccharomyces. Mycopathologia. 1975;55(1):29–34.PubMedCrossRefGoogle Scholar
  17. 17.
    Siccardi D, Rellini P, Corte L, Bistoni F, Fatichetti F, Cardinali G. General evidence supporting the hypothesis that Saccharomyces cerevisiae vaginal isolates originate from food industrial environments. New Microbiol. 2006;29(3):201–6.PubMedGoogle Scholar
  18. 18.
    Iwata K. Fungal toxins as a parasitic factor responsible for the establishment of fungal infections. Mycopathologia. 1978;65(1–3):141–54.PubMedCrossRefGoogle Scholar
  19. 19.
    Mancianti F, Nardoni S, Ceccherelli R. Occurrence of yeasts in psittacines droppings from captive birds in Italy. Mycopathologia. 2002;153(3):121–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Papavassiliou JT, Bartzokas CA. The atmospheric fungal flora of the Athens metropolitan area. Mycopathologia. 1975;57(1):31–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive fungal infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis. 1990;12:406–11.PubMedGoogle Scholar
  22. 22.
    Belet N, Dalgic N, Oncel S, Ciftci E, Guriz H, Barlas M, Dogru U. Catheter-related fungemia by Saccharomyces cerevisiae in a newborn. Pediatr Infect Dis J. 2005;24(12):1125.PubMedCrossRefGoogle Scholar
  23. 23.
    De Llanos R, Querol A, Peman J, Gobernado M, Fernandez-Espinar MT. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int J Food Microbiol. 2006;110(3):286–90.PubMedCrossRefGoogle Scholar
  24. 24.
    Enache-Angoulvant A, Hennequin C. Invasive Saccharomyces cerevisiae infection: a comprehensive review. Clin Infect Dis. 2005;41(11):1559–68.PubMedCrossRefGoogle Scholar
  25. 25.
    Williams JS, Mufti GJ, Powell S, Salisbury JR, Higgins EM. Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed myeloid leukemia. Clin Exp Dermatol. 2007;32(4):395–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Barefoot SF, Klaenhammer TR. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol. 1983;45:1808–15.PubMedGoogle Scholar
  27. 27.
    Galask RP. Vaginal colonization by bacteria and yeasts. Am J Obstet Gynecol. 1989;158:993–5.Google Scholar
  28. 28.
    Consolaro ME, Gasparetto A, Svidzinski TI, Peralta RM. Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions. Mycopathologia. 2006;162(2):75–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Lehrer N, Segal E, Lis H, Gov Y. Effect of Candida albicans cell wall components on the adhesion of the fungus to human and murine vaginal mucosa. Mycopathologia. 1988;102(2):115–21.PubMedCrossRefGoogle Scholar
  30. 30.
    Lopez-Martinez R, Ruiz-Sanchez D, Vertiz-Chavez E. Vaginal candidiasis. Opportunistic factors and clinical correlation in 600 patients. Mycopathologia. 1984;85(3):167–70.PubMedGoogle Scholar
  31. 31.
    Marcano C, Feo M. Effectiveness of econazole on pregnant women with vulvo-vaginal candidiasis. Mycopathologia. 1983;81(2):65–70.PubMedCrossRefGoogle Scholar
  32. 32.
    Warnock DW, Milne JD, Fielding AM. Immunoglobulin classes of human serum antibodies in vaginal candidiasis. Mycopathologia. 1978;63(3):173–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Bulmer GS, Marquez ML, Co-Barcelona L, Fromtling RA. Yeasts and fluconazole susceptibility in the Philippines. Mycopathologia. 1999;146(3):117–20.PubMedCrossRefGoogle Scholar
  34. 34.
    Candido RC, Toloi MR, Franceschini SA, Garcia FR, Minto EC. In vivo activity of antimycotic agents determined by E-test method against vaginal Candida species. Mycopathologia. 1998–1999;144(1):15–20.CrossRefGoogle Scholar
  35. 35.
    Costa M, Passos XS, Miranda AT, de Araujo RS, Paula CR, Silva Mdo R. Correlation of in vivo itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis. Mycopathologia. 2004;157(1):43–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Ribeiro MA, Dietze R, Paula CR, Da Matta DA, Colombo AL. Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia. 2001;151(1):5–10.PubMedCrossRefGoogle Scholar
  37. 37.
    Ringel SM. New antifungal agents for the systemic mycoses. Mycopathologia. 1990;109(2):75–87.PubMedCrossRefGoogle Scholar
  38. 38.
    Sojakova M, Liptajova D, Borovsky M, Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia. 2004;157(2):163–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Hussain Qadri SM, Flournoy DJ, Qadri SG, Ramirez EG. Susceptibility of clinical isolates of yeasts to anti-fungal agents. Mycopathologia. 1986;95(3):183–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Vincenzo Savini
    • 1
  • Chiara Catavitello
    • 1
  • Assunta Manna
    • 1
  • Marzia Talia
    • 1
  • Fabio Febbo
    • 1
  • Andrea Balbinot
    • 1
  • Francesco D’Antonio
    • 2
  • Giovanni Di Bonaventura
    • 3
  • Claudio Celentano
    • 2
  • Marco Liberati
    • 2
  • Raffaele Piccolomini
    • 3
  • Domenico D’Antonio
    • 1
  1. 1. Clinical Microbiology and Virology Unit, Department of Transfusion Medicine“Spirito Santo” HospitalPescaraItaly
  2. 2.Department of Obstetrics and Gynecology“Gabriele D’Annunzio” University School of MedicineChietiItaly
  3. 3.Clinical Microbiology, Aging Research Center (Ce.S.I), and Department of Biomedical Sciences“Gabriele D’Annunzio” University School of MedicineChietiItaly

Personalised recommendations